BRPI0807222A2 - Análogos de neucleosídeo para tratamento de infecções virais - Google Patents

Análogos de neucleosídeo para tratamento de infecções virais

Info

Publication number
BRPI0807222A2
BRPI0807222A2 BRPI0807222-1A2A BRPI0807222A BRPI0807222A2 BR PI0807222 A2 BRPI0807222 A2 BR PI0807222A2 BR PI0807222 A BRPI0807222 A BR PI0807222A BR PI0807222 A2 BRPI0807222 A2 BR PI0807222A2
Authority
BR
Brazil
Prior art keywords
treatment
viral infections
nucleoside analogs
nucleoside
analogs
Prior art date
Application number
BRPI0807222-1A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Zheng Yin
Jeyaraj Duraiswamy
Yen Liang Chen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0807222(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0807222A2 publication Critical patent/BRPI0807222A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0807222-1A2A 2007-02-09 2008-02-07 Análogos de neucleosídeo para tratamento de infecções virais BRPI0807222A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02
PCT/EP2008/051527 WO2008095993A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Publications (1)

Publication Number Publication Date
BRPI0807222A2 true BRPI0807222A2 (pt) 2014-04-29

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807222-1A2A BRPI0807222A2 (pt) 2007-02-09 2008-02-07 Análogos de neucleosídeo para tratamento de infecções virais

Country Status (18)

Country Link
US (1) US8278282B2 (cg-RX-API-DMAC7.html)
EP (1) EP2132216B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010518047A (cg-RX-API-DMAC7.html)
KR (1) KR20090109102A (cg-RX-API-DMAC7.html)
CN (1) CN101600726B (cg-RX-API-DMAC7.html)
AR (1) AR065249A1 (cg-RX-API-DMAC7.html)
AT (1) ATE533774T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008212752A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0807222A2 (cg-RX-API-DMAC7.html)
CA (1) CA2675462A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008000409A1 (cg-RX-API-DMAC7.html)
EA (1) EA200901080A1 (cg-RX-API-DMAC7.html)
ES (1) ES2381093T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009008495A (cg-RX-API-DMAC7.html)
PE (1) PE20090070A1 (cg-RX-API-DMAC7.html)
PT (1) PT2132216E (cg-RX-API-DMAC7.html)
TW (1) TW200838550A (cg-RX-API-DMAC7.html)
WO (1) WO2008095993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
JP2018523665A (ja) 2015-08-06 2018-08-23 キメリックス インコーポレイテッド 抗ウイルス剤として有用なピロロピリミジンヌクレオシドおよびその類縁体
RU2720811C2 (ru) 2015-09-23 2020-05-13 Мерк Шарп И Доум Лимитед 4'-замещенные нуклеозидные ингибиторы обратной транскриптазы и их получение
EA201892448A1 (ru) * 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
TW201811339A (zh) * 2016-08-12 2018-04-01 美商艾洛斯生物製藥公司 經取代之核苷、核苷酸及其類似物
EP3684771B1 (en) 2017-09-21 2024-11-27 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo(2,3-d)pyrimidine-5-carboxamide and uses thereof
US11718534B2 (en) 2019-04-23 2023-08-08 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
US20250057849A1 (en) * 2021-12-22 2025-02-20 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117430571B (zh) * 2022-07-15 2025-08-29 宜昌东阳光长江药业股份有限公司 一种制备吡喃葡萄糖基衍生物的关键中间体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206614A (pt) * 2001-01-22 2004-02-17 Merck & Co Inc Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
JP2005527499A (ja) * 2002-02-13 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
MXPA04010983A (es) * 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
WO2005042556A1 (en) * 2003-10-27 2005-05-12 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections

Also Published As

Publication number Publication date
CA2675462A1 (en) 2008-08-14
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
PE20090070A1 (es) 2009-03-19
WO2008095993A1 (en) 2008-08-14
AU2008212752A1 (en) 2008-08-14
JP2010518047A (ja) 2010-05-27
ATE533774T1 (de) 2011-12-15
US20100227833A1 (en) 2010-09-09
CN101600726A (zh) 2009-12-09
EP2132216A1 (en) 2009-12-16
EP2132216B1 (en) 2011-11-16
AR065249A1 (es) 2009-05-27
MX2009008495A (es) 2009-08-20
PT2132216E (pt) 2012-02-20
KR20090109102A (ko) 2009-10-19
US8278282B2 (en) 2012-10-02
TW200838550A (en) 2008-10-01
CN101600726B (zh) 2013-03-27
EA200901080A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
BRPI0807222A2 (pt) Análogos de neucleosídeo para tratamento de infecções virais
IL213964A0 (en) Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
BRPI0922508A2 (pt) Análogos de nucleosídeo
BRPI0911410A2 (pt) análogos de carba-nucleosídeo para tratamento antiviral
HUE040541T2 (hu) Purin-származékok vírusfertõzések kezelésére
DK2114980T3 (da) Antivirale nukleosidanaloger
BRPI1013643A2 (pt) análogos de carba-nucleosídeo para tratamento antiviral
HUE055286T2 (hu) Pirimidinszármazékok vírusfertõzések kezelésére
EP2266064A4 (en) ROUTES OF REQUIREMENTS
BR112013029761A2 (pt) pró-drogas de monofosfato de purina para tratamento de infecções virais
BRPI0718548A2 (pt) Estabilização de vacinas por liofilização
DK2576534T3 (da) 1-Substitueret-carba-nukleosid prodrugs til antiviral behandling
AP3103A (en) Derivatives of purine or deazapurine useful for the treatment of (inter alia)viral infections
BRPI0819797A2 (pt) compostos de nucleosídeos antivirais
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
BR112013008017A2 (pt) análogos de carba-nucleosídeo 2-flúor substituídos para tratamento antiviral
CL2014001641A1 (es) Compuestos derivados de nucleosidos sustituidos, nucleotidos y analogos de los mismos; composicion farmaceutica; y uso para mejorar o tratar una infeccion viral.
DK2528930T3 (da) 4'-azido-nukleosider som anti-hcv-forbindelser
DK2222272T3 (da) Behandling af luftvejssygdom
BR112012008959A2 (pt) tratamento de terapia de combinação para infecções virais
EP2776438A4 (en) SUBSTITUTED PURIN NUCLEOSIDES, PHOSPHORAMIDATE AND PHOSPHORDIAMIDATE DERIVATIVES FOR THE TREATMENT OF VIRUS INFECTIONS
EP1971589A4 (en) PROCESS FOR PREPARING 3-HYDROXYTETRAHYDROFURAN BY MEANS OF CYCLODE HYDROGENATION
IT1393062B1 (it) Procedimento per la preparazione di gemcitabina cloridrato
BR112013011405A2 (pt) composição farmacêutica para tratar infecções por hcv

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.